Supplemental Reading

Choice of lipid-regulating drugs. Med Lett 2001;43 (Issue 1105):43—48.

Collins R, Peto R, and Armitage J. The MCR/BHF: Heart Protection Study: preliminary results. Int J Clin Pract 2002;56:53-56.

Contemporary management of lipid disorders: The evolving importance of statin therapy. Clin Courier 1998;28 (No. 35):1-7.

Downs JR et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of AFCAPS/TEX-CAPS. JAMA 1998;279:1615-1622.

Knopp RH. Drug treatment of lipid disorders. N Engl J Med 1999;341:498-511.

Ornish D et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA 1998;280:2001-2007.

Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999;340:115-126.

Sacks FM et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-1009.

Shepherd J et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333:1301-1307.

Tanne D et al. Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Benzafibrate Infarction Prevention (BIP) Registry: High triglycerides constitute an independent risk factor. Circulation 2001;104:2892-2897.

Coping with Asthma

Coping with Asthma

If you suffer with asthma, you will no doubt be familiar with the uncomfortable sensations as your bronchial tubes begin to narrow and your muscles around them start to tighten. A sticky mucus known as phlegm begins to produce and increase within your bronchial tubes and you begin to wheeze, cough and struggle to breathe.

Get My Free Ebook


Post a comment